Alpha Teknova (TKNO) Reports Prelim Q4 Revenue of $10-$10.1M

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. AXP
9. TMUS
10. SPY

Go back to Alpha Teknova (TKNO) Reports Prelim Q4 Revenue of $10-$10.1M

Teknova Announces Preliminary Revenue of $10.0 to $10.1 Million for the Fourth Quarter 2021

February 28, 2022 8:15 AM EST

Company to participate in two upcoming investor conferences in March 2022

HOLLISTER, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (Teknova) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, today announced preliminary unaudited revenue for the fourth quarter ended December 31, 2021, of $10.0 to $10.1 million, including Sample Transport of approximately $0.5 million.   Excluding Sample Transport, total unaudited revenue for the fourth quarter ended December 31, 2021, was $9.5 to $9.6 million.

"Our team delivered an outstanding finish to 2021, resulting in... More